[Drugs dosing in intensive care unit during continuous renal replacement therapy].
Drug dosing in the intensive care unit can be challenging. Acute kidney injury (AKI) is a common complication of sepsis and a part of multiple organ dysfunction syndrome. Continuous renal replacement therapy (CRRT) is increasingly used as dialysis therapy in this critically ill population. Available data demonstrate that sepsis, AKI and different modalities of CRRT can profoundly change drugs pharmacokinetic. The severity of these changes depends on molecules characteristics (volume of distribution, plasma protein binding, molecular weight, plasma half-life, plasma clearance), patient itself (volemia, residual renal function, tissue perfusion, hepatic dysfunction) and modality of CRRT (diffusion, convection, adsorption). There are no available recommendations to adapt drug dosing in a given critically ill patient with a given modality of CRRT. It is necessary to fully understand the different methods of CRRT and drug pharmacokinetic to prescribe the appropriate dose and to avoid under or potentially toxic overdosing. Monitoring the plasma level of drug - when available - can establish a relation between the blood concentration and its effect; thus, facilitating drug dosing.
Service de néphrologie, département de médecine interne, hôpitaux universitaires de Genève (HUG), 1211 Genève, Suisse.
Vincent
V
Bourquin
Belén
B
Ponte
Patrick
P
Saudan
Pierre-Yves
PY
Martin
D054796:Drug Dosage Calculations; D006801:Humans; D007362:Intensive Care Units; D010599:Pharmacokinetics; D017582:Renal Replacement Therapy